Three Months Ended June 30
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
215,372
|
$
|
202,480
|
$
|
215,372
|
$
|
202,480
|
||||||||
Gross margin
|
48.5
|
%
|
47.8
|
%
|
48.7
|
%
|
48.2
|
%
|
||||||||
Income from operations
|
$
|
31,694
|
$
|
37,593
|
$
|
41,464
|
$
|
51,935
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
29,760
|
$
|
24,210
|
$
|
36,800
|
$
|
37,521
|
||||||||
Basic EPS
|
$
|
0.47
|
$
|
0.39
|
$
|
0.58
|
$
|
0.60
|
||||||||
Diluted EPS
|
$
|
0.44
|
$
|
0.35
|
$
|
0.54
|
$
|
0.55
|
Six Months Ended June 30
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
387,719
|
$
|
354,671
|
$
|
387,719
|
$
|
354,671
|
||||||||
Gross margin
|
48.2
|
%
|
49.6
|
%
|
48.5
|
%
|
50.0
|
%
|
||||||||
Income from operations
|
$
|
57,471
|
$
|
62,825
|
$
|
77,058
|
$
|
91,736
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
50,140
|
$
|
41,643
|
$
|
68,079
|
$
|
72,118
|
||||||||
Basic EPS
|
$
|
0.79
|
$
|
0.67
|
$
|
1.07
|
$
|
1.17
|
||||||||
Diluted EPS
|
$
|
0.74
|
$
|
0.61
|
$
|
1.01
|
$
|
1.07
|
(1) |
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to
Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain
(loss) on short-term investments.
|
• |
Shipments. Total
shipments in the second quarter of 2025 were $206.4 million, up 1.9% from the second quarter of 2024. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for
potential revenue in future quarters.
|
• |
Upgraded Ultra C wb Wet Bench Cleaning Tool with Patent-Pending N₂ Bubbling
Technology. ACM announced major upgrades to its Ultra C wb cleaning tool, featuring a patent-pending nitrogen (N₂) bubbling technique that improves wet etching
uniformity by over 50% and enhances particle removal performance for advanced-node applications.
|
• |
Delivery of 1,500th ECP Chamber. ACM delivered an ECP tool to a customer in China, which included ACM’s 1,500th electroplating chamber shipped. This milestone highlights ACM’s continued growth in plating technology adoption and reinforces
its leadership in high-performance electroplating equipment for advanced semiconductor manufacturing.
|
• |
Second Quarter 2025 Financial Summary
|
• |
Revenue was $215.4
million, up 6.4%, reflecting modest growth from single wafer
cleaning, Tahoe and semi-critical cleaning equipment, and higher sales of ECP (front-end and packaging), furnace and other technologies, and advanced packaging
(excluding ECP), services & spares.
|
• |
Gross margin was 48.5% versus 47.8%. Non-GAAP gross margin, which excludes stock-based compensation, was 48.7% versus 48.2%. Gross margin exceeded the high end of ACM’s long-term business model target range of 40%
to 45%. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
|
• |
Operating expenses were $72.8 million, an increase of 22.9%. Operating expenses as a percentage of revenue increased to 33.8% from 29.2%. Non-GAAP operating expenses, which exclude the effect of stock-based
compensation, were $63.4 million, up 38.8%. Non-GAAP operating
expenses as a percentage of revenue increased to 29.4% from 22.5%.
|
• |
Operating income was $31.7 million, compared to $37.6 million. Operating margin was 14.7% compared to 18.6%. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $41.5 million, compared to $51.9 million. Non-GAAP operating margin,
which excludes stock-based compensation, was 19.3% compared to 25.6%.
|
• |
Unrealized gain on short-term investments was $2.7 million, compared to an unrealized gain of $1.0 million. Unrealized gain reflects the change in market
value of the investments by ACM’s principal operating subsidiary, ACM Research (Shanghai), Inc. The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
|
• |
Income tax expense was $1.9 million, compared to $9.3 million.
|
• |
Net income attributable to ACM Research, Inc. was $29.8 million, compared to $24.2 million. Non-GAAP net income attributable to ACM Research,
Inc., which excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $36.8 million, compared to $37.5 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $0.44, compared to $0.35. Non-GAAP net income per diluted share, which
excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $0.54, compared to $0.55.
|
• |
Cash and cash equivalents, plus restricted cash and short-term and long-term time deposits
were $483.9 million at June 30, 2025, compared to $498.4 million
at March 31, 2025.
|
In the United States:
|
The Blueshirt Group
|
Steven C. Pelayo, CFA
|
|
(360) 808-5154
|
|
steven@blueshirtgroup.co
|
|
In China:
|
The Blueshirt Group Asia
|
Gary Dvorchak, CFA
|
|
+86 (138) 1079-1480
|
|
gary@blueshirtgroup.co
|
June 30, 2025
|
December 31, 2024
|
|||||||
(Unaudited)
|
||||||||
(In thousands)
|
||||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
442,088
|
$
|
407,445
|
||||
Restricted cash
|
10,798
|
3,865
|
||||||
Short-term time deposits
|
31,019
|
17,277
|
||||||
Short-term investment
|
21,115
|
19,373
|
||||||
Accounts receivable, net
|
433,662
|
387,045
|
||||||
Other receivables
|
43,708
|
41,859
|
||||||
Inventories, net
|
648,278
|
597,984
|
||||||
Advances to related parties
|
682
|
1,024
|
||||||
Prepaid expenses and other current assets
|
14,303
|
7,507
|
||||||
Total current assets
|
1,645,653
|
1,483,379
|
||||||
Property, plant and equipment, net
|
290,944
|
269,272
|
||||||
Operating lease right-of-use assets, net
|
17,285
|
14,038
|
||||||
Intangible assets, net
|
2,849
|
3,461
|
||||||
Long-term time deposits
|
—
|
13,275
|
||||||
Deferred tax assets
|
22,341
|
14,781
|
||||||
Long-term investments
|
56,723
|
37,063
|
||||||
Other long-term assets
|
3,920
|
20,452
|
||||||
Total assets
|
$
|
2,039,715
|
$
|
1,855,721
|
||||
Liabilities and Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
$
|
52,969
|
$
|
32,814
|
||||
Current portion of long-term borrowings
|
62,139
|
44,472
|
||||||
Related parties accounts payable
|
19,827
|
16,133
|
||||||
Accounts payable
|
148,780
|
139,294
|
||||||
Advances from customers
|
221,446
|
243,949
|
||||||
Deferred revenue
|
13,660
|
8,537
|
||||||
Income taxes payable
|
253
|
12,779
|
||||||
FIN-48 payable
|
21,373
|
19,466
|
||||||
Other payables and accrued expenses
|
126,787
|
121,657
|
||||||
Current portion of operating lease liability
|
3,778
|
2,132
|
||||||
Total current liabilities
|
671,012
|
641,233
|
||||||
Long-term borrowings
|
162,991
|
105,525
|
||||||
Long-term operating lease liability
|
5,496
|
3,840
|
||||||
Other long-term liabilities
|
8,527
|
9,217
|
||||||
Total liabilities
|
848,026
|
759,815
|
||||||
Commitments and contingencies
|
||||||||
Equity:
|
||||||||
Stockholders’ equity:
|
||||||||
Class A Common stock
|
6
|
6
|
||||||
Class B Common stock
|
1
|
1
|
||||||
Additional paid-in capital
|
704,570
|
677,476
|
||||||
Retained earnings
|
310,140
|
260,000
|
||||||
Statutory surplus reserve
|
30,514
|
30,514
|
||||||
Accumulated other comprehensive loss
|
(58,781
|
)
|
(63,372
|
)
|
||||
Total ACM Research, Inc. stockholders’ equity
|
986,450
|
904,625
|
||||||
Non-controlling interests
|
205,239
|
191,281
|
||||||
Total equity
|
1,191,689
|
1,095,906
|
||||||
Total liabilities and equity
|
$
|
2,039,715
|
$
|
1,855,721
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
( In thousands, except share and per share data)
|
||||||||||||||||
Revenue
|
$
|
215,372
|
$
|
202,480
|
$
|
387,719
|
$
|
354,671
|
||||||||
Cost of revenue
|
110,911
|
105,696
|
200,708
|
178,766
|
||||||||||||
Gross profit
|
104,461
|
96,784
|
187,011
|
175,905
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Sales and marketing
|
22,102
|
17,135
|
38,445
|
31,308
|
||||||||||||
Research and development
|
33,817
|
25,968
|
61,320
|
49,886
|
||||||||||||
General and administrative
|
16,848
|
16,088
|
29,775
|
31,886
|
||||||||||||
Total operating expenses
|
72,767
|
59,191
|
129,540
|
113,080
|
||||||||||||
Income from operations
|
31,694
|
37,593
|
57,471
|
62,825
|
||||||||||||
Interest income
|
4,013
|
2,381
|
7,352
|
4,155
|
||||||||||||
Interest expense
|
(1,757
|
)
|
(932
|
)
|
(3,315
|
)
|
(1,715
|
)
|
||||||||
Realized gain on short-term investments
|
54
|
-
|
54
|
273
|
||||||||||||
Unrealized gain (loss) on short-term investments
|
2,730
|
1,031
|
1,648
|
(1,564
|
)
|
|||||||||||
Other (expense) income, net
|
(346
|
)
|
1,357
|
(608
|
)
|
4,437
|
||||||||||
Income (loss) from equity method investments
|
1,773
|
(695
|
)
|
2,725
|
(1,215
|
)
|
||||||||||
Income before income taxes
|
38,161
|
40,735
|
65,327
|
67,196
|
||||||||||||
Income tax expense
|
(1,891
|
)
|
(9,336
|
)
|
(4,044
|
)
|
(13,705
|
)
|
||||||||
Net income
|
36,270
|
31,399
|
61,283
|
53,491
|
||||||||||||
Less: Net income attributable to non-controlling interests
|
6,510
|
7,189
|
11,143
|
11,848
|
||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
29,760
|
$
|
24,210
|
$
|
50,140
|
$
|
41,643
|
||||||||
Comprehensive income:
|
||||||||||||||||
Net income
|
36,270
|
31,399
|
61,283
|
53,491
|
||||||||||||
Foreign currency translation adjustment, net of tax of nil
|
3,905
|
116
|
5,655
|
(6,713
|
)
|
|||||||||||
Comprehensive Income
|
40,175
|
31,515
|
66,938
|
46,778
|
||||||||||||
Less: Comprehensive income attributable to non-controlling interests
|
7,250
|
7,210
|
12,207
|
10,616
|
||||||||||||
Comprehensive income attributable to ACM Research, Inc.
|
$
|
32,925
|
$
|
24,305
|
$
|
54,731
|
$
|
36,162
|
||||||||
Net income attributable to ACM Research, Inc. per common share:
|
||||||||||||||||
Basic
|
$
|
0.47
|
$
|
0.39
|
$
|
0.79
|
$
|
0.67
|
||||||||
Diluted
|
$
|
0.44
|
$
|
0.35
|
$
|
0.74
|
$
|
0.61
|
||||||||
Weighted average common shares outstanding used in computing per share amounts:
|
||||||||||||||||
Basic
|
63,968,763
|
62,178,369
|
63,620,235
|
61,772,776
|
||||||||||||
Diluted
|
67,464,856
|
67,057,846
|
67,138,338
|
66,520,706
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
($ in thousand)
|
||||||||||||||||
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
|
$
|
154,961
|
$
|
153,221
|
$
|
284,530
|
$
|
262,691
|
||||||||
ECP (front-end and packaging), furnace and other technologies
|
48,016
|
38,962
|
75,646
|
64,762
|
||||||||||||
Advanced packaging (excluding ECP), services & spares
|
12,395
|
10,297
|
27,543
|
27,218
|
||||||||||||
Total Revenue By Product Category
|
$
|
215,372
|
$
|
202,480
|
$
|
387,719
|
$
|
354,671
|
Three Months Ended June 30,
|
||||||||||||||||||||||||||||||||
2025
|
2024
|
|||||||||||||||||||||||||||||||
Actual
(GAAP)
|
SBC
|
Other non-
operating adjustments
|
Adjusted
(Non-
GAAP)
|
Actual
(GAAP)
|
SBC
|
Other non-
operating adjustments
|
Adjusted
(Non-
GAAP)
|
|||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
215,372
|
$
|
-
|
$
|
-
|
$
|
215,372
|
$
|
202,480
|
$
|
-
|
$
|
-
|
$
|
202,480
|
||||||||||||||||
Cost of revenue
|
(110,911
|
)
|
(356
|
)
|
-
|
(110,555
|
)
|
(105,696
|
)
|
(792
|
)
|
-
|
(104,904
|
)
|
||||||||||||||||||
Gross profit
|
104,461
|
(356
|
)
|
-
|
104,817
|
96,784
|
(792
|
)
|
-
|
97,576
|
||||||||||||||||||||||
Gross margin
|
48.5
|
%
|
0.2
|
%
|
-
|
48.7
|
%
|
47.8
|
%
|
0.4
|
%
|
-
|
48.2
|
%
|
||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(22,102
|
)
|
(2,096
|
)
|
-
|
(20,006
|
)
|
(17,135
|
)
|
(3,024
|
)
|
-
|
(14,111
|
)
|
||||||||||||||||||
Research and development
|
(33,817
|
)
|
(2,580
|
)
|
-
|
(31,237
|
)
|
(25,968
|
)
|
(4,206
|
)
|
-
|
(21,762
|
)
|
||||||||||||||||||
General and administrative
|
(16,848
|
)
|
(4,738
|
)
|
-
|
(12,110
|
)
|
(16,088
|
)
|
(6,320
|
)
|
-
|
(9,768
|
)
|
||||||||||||||||||
Total operating expenses
|
(72,767
|
)
|
(9,414
|
)
|
-
|
(63,353
|
)
|
(59,191
|
)
|
(13,550
|
)
|
-
|
(45,641
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
31,694
|
$
|
(9,770
|
)
|
$
|
-
|
$
|
41,464
|
$
|
37,593
|
$
|
(14,342
|
)
|
$
|
-
|
$
|
51,935
|
||||||||||||||
Unrealized gain on short-term investments
|
2,730
|
-
|
2,730
|
-
|
1,031
|
-
|
1,031
|
-
|
||||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
29,760
|
$
|
(9,770
|
)
|
$
|
2,730
|
$
|
36,800
|
$
|
24,210
|
$
|
(14,342
|
)
|
$
|
1,031
|
$
|
37,521
|
||||||||||||||
Basic EPS
|
$
|
0.47
|
$
|
0.58
|
$
|
0.39
|
$
|
0.60
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.44
|
$
|
0.54
|
$
|
0.35
|
$
|
0.55
|
Six Months Ended June 30,
|
||||||||||||||||||||||||||||||||
2025
|
2024
|
|||||||||||||||||||||||||||||||
Actual
(GAAP)
|
SBC
|
Other non-
operating adjustments
|
Adjusted
(Non-
GAAP)
|
Actual
(GAAP)
|
SBC
|
Other non-
operating adjustments
|
Adjusted
(Non-
GAAP)
|
|||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
387,719
|
$
|
-
|
$
|
-
|
$
|
387,719
|
$
|
354,671
|
$
|
-
|
$
|
-
|
$
|
354,671
|
||||||||||||||||
Cost of revenue
|
(200,708
|
)
|
(885
|
)
|
-
|
(199,823
|
)
|
(178,766
|
)
|
(1,573
|
)
|
-
|
(177,193
|
)
|
||||||||||||||||||
Gross profit
|
187,011
|
(885
|
)
|
-
|
187,896
|
175,905
|
(1,573
|
)
|
-
|
177,478
|
||||||||||||||||||||||
Gross margin
|
48.2
|
%
|
0.2
|
%
|
-
|
48.5
|
%
|
49.6
|
%
|
0.4
|
%
|
-
|
50.0
|
%
|
||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(38,445
|
)
|
(4,253
|
)
|
-
|
(34,192
|
)
|
(31,308
|
)
|
(6,051
|
)
|
-
|
(25,257
|
)
|
||||||||||||||||||
Research and development
|
(61,320
|
)
|
(5,355
|
)
|
-
|
(55,965
|
)
|
(49,886
|
)
|
(8,709
|
)
|
-
|
(41,177
|
)
|
||||||||||||||||||
General and administrative
|
(29,775
|
)
|
(9,094
|
)
|
-
|
(20,681
|
)
|
(31,886
|
)
|
(12,578
|
)
|
-
|
(19,308
|
)
|
||||||||||||||||||
Total operating expenses
|
(129,540
|
)
|
(18,702
|
)
|
-
|
(110,838
|
)
|
(113,080
|
)
|
(27,338
|
)
|
-
|
(85,742
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
57,471
|
$
|
(19,587
|
)
|
$
|
-
|
$
|
77,058
|
$
|
62,825
|
$
|
(28,911
|
)
|
$
|
-
|
$
|
91,736
|
||||||||||||||
Unrealized gain (loss) on short-term investments
|
1,648
|
-
|
1,648
|
-
|
(1,564
|
)
|
-
|
(1,564
|
)
|
-
|
||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
50,140
|
$
|
(19,587
|
)
|
$
|
1,648
|
$
|
68,079
|
$
|
41,643
|
$
|
(28,911
|
)
|
$
|
(1,564
|
)
|
$
|
72,118
|
|||||||||||||
Basic EPS
|
$
|
0.79
|
$
|
1.07
|
$
|
0.67
|
$
|
1.17
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.74
|
$
|
1.01
|
$
|
0.61
|
$
|
1.07
|